FTC says Martin Shkreli violated lifetime pharmaceutical-industry ban in biotech livestream
The Federal Trade Commission says Martin Shkreli breached a lifetime ban from the pharmaceutical industry by livestreaming discussion of biotech stocks. The available report does not set out the ban’s terms, the livestream’s content or any enforcement action sought.